June 1, 2009

ABBOTT LABS: To Enforce Niaspan(R) Patent Rights v. Lupin Pharma

COMPANIES: Abbott Laboratories Inc | Lupin Ltd (fka Lupin Chemicals Ltd) | Lupin Pharmaceuticals Inc
Subscribe

Abbott Laboratories is seeking to enforce its patent rights relating to niacin extended release tablets, according to the Company’s latest Quarterly Report filed with the U.S. Securities and Exchange Commission…

TO CONTINUE READING,LOGIN or
TOPICS: Commercial Services | Drugs/Pharmaceuticals | Health Care | Legal Issues, Litigation | Patents, Intellectual Prop. | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US
LOCATIONS: Illinois | United States